Time Commitment: 3 hours and 30 minutes over 56 days
Credits Available: 3.50 AMA PRA Category 1 Credit

Spinal muscular atrophy (SMA) can be a debilitating condition causing immobility, respiratory difficulties, and reduced lifespan. But with the advent of new disease-modifying therapies, the prognosis for patients with SMA has been completely altered. These treatments may help patients live longer, creating unique clinical needs. Adults now make up more than a quarter of patients with SMA. However, there are no specific guidelines for the assessment and treatment of adult patients, leading to gaps in their diagnosis and management. Adult care is complex and requires multidisciplinary care. This collaborative CME provides the opportunity to learn and share best practices that will improve outcomes for patients with SMA.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, MBBS, Nurse Practitioner, Nurse, Physician Assistant, Social Worker, Physical Therapist, Pharmacist, Healthcare Navigator
Target Specialties: Neurology, Pulmonary/Respiratory Physician, Physiatry/Rehabilitation, Genetics/Genomics, Orthopedic Medicine/Sports Medicine, Pharmacy, Nutrition, Pediatrics

Mario Saporta

University of Miami Miller School of Medicine
Associate Professor of Neurology and Human Genetics

I am a clinician-scientist and adult neurologist focused on neuromuscular genetic conditions. I lead a multidisciplinary care center for patients with Spinal Muscular Atrophy, Charcot-Marie-Tooth disease and Muscular Dystrophies. My research interests spans from bench translational work to develop new treatments for genetic neuropathies to clinical trials to validate new treatments for neuromuscular genetic conditions.